INDP
Indaptus Therapeutics Inc
NASDAQ: INDP · HEALTHCARE · BIOTECHNOLOGY
$2.80
-4.11% today
Updated 2026-04-30
Market cap
$7.69M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-21.58
Dividend yield
—
52W range
$2 – $20
Volume
0.1M
Indaptus Therapeutics Inc (INDP) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-3.78M | $-3.08M | $-4.31M | $-5.38M | $-4.50M | $-3.38M | $-4.75M | $-7.93M | $-12.01M | $-22.13M | $-39.08M | $-29.05M | $-3.32M | $-11.29M | $-13.08M | $-13.41M | $-12.32M | $-14.82M |
| Capital expenditures | $203218.00 | $528825.00 | $474773.00 | $2.31M | $206404.00 | $1.49M | $75760.00 | $1.39M | $482000.00 | $5.00M | $9.60M | $920999.00 | $8.21M | $3854.00 | $172555.00 | $5.00 | $0.00 | $4.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | — | — | — | — | — | — | — | — | — | — | $124367.00 | $139960.00 | $1.51M | $2.96M | $2.97M | $2.31M | $1.36M |
| Free cash flow | $-3.98M | $-3.61M | $-4.79M | $-7.69M | $-4.71M | $-4.87M | $-4.83M | $-9.32M | $-12.49M | $-27.13M | $-48.67M | $-29.97M | $-11.53M | $-11.29M | $-13.25M | $-13.41M | $-12.32M | $-14.82M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |